ClinicalTrials.Veeva

Menu

Effect of Paracetamol,Pregabalin and Dexamethasone on Pain and Opioid Requirements in Postoperative Patients

G

Glostrup University Hospital, Copenhagen

Status and phase

Completed
Phase 4

Conditions

Pain, Postoperative

Treatments

Drug: Pregabalin; Dexamethasone

Study type

Interventional

Funder types

Other

Identifiers

Details and patient eligibility

About

Women scheduled for abdominal hysterectomy needs postoperative pain treatment, i.e. morphine. Unfortunately morphine has side-effect: nausea, vomiting, sedation and dizziness, which is unpleasant for the patients and sometimes keeps them at bed longer time than needed. We investigate in new combinations of analgesics for postoperative pain, hoping to minimize the need for morphine.

Full description

Combinations of paracetamol versus paracetamol + pregabalin versus paracetamol + pregabalin + dexamethasone is investigated. Primary outcome is 24 hours morphine usage.

Enrollment

130 patients

Sex

Female

Ages

18 to 75 years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Women scheduled for abdominal hysterectomy, between the age of 18 and 75, ASA 1-2
  • BMI between 18-32.

Exclusion criteria

Patients who:

  • Are unable to cooperate
  • Has cancer ovarian
  • Does not speak Danish
  • Has allergy for drugs used in the trial
  • Has drug and medicine abuse
  • Epilepsy
  • Diabetes treated with medicine
  • Chronic pain condition
  • Daily use of antacids or analgesic
  • Known kidney disease
  • Use of antidepressive

Trial design

130 participants in 3 patient groups, including a placebo group

A
Placebo Comparator group
Treatment:
Drug: Pregabalin; Dexamethasone
B
Experimental group
Description:
Pregabalin
Treatment:
Drug: Pregabalin; Dexamethasone
C
Experimental group
Description:
Pregabalin + dexamethasone
Treatment:
Drug: Pregabalin; Dexamethasone

Trial contacts and locations

2

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2025 Veeva Systems